• Latest Posts

7 Trendy European Biotechs Listed on the NASDAQ in 2016

Biotech of the Week: Synpromics, the Scottish company enabling precise Gene Expression

UniQure’s cure for rare Lysosomal disease ready for phase III trial

FDA shelves UniQure’s Glybera – will the Gene therapy once reach the US market?

A Tale of Love for UniQure and Bristol-Myers Squibb


GSK sparks off the Gene Therapy resurgence

A New Key Strategic Collaboration Between BMS and UniQure

Synpromics and UniQure, new Collaboration in Gene Therapy.

Forbion Capital Partners: a Leading European Biotech VC is rising!

uniQure acquires the gene therapy start-up InoCard